New Indications for Novel Fluoroquinolones: Moxifloxacin in the Treatment of Nosocomial Infections
Saved in:
| Main Authors: | N. V. Beloborodova, D. A. Popov, T. YU. Vostrikova, E. N. Bachinskaya, S. T. Kuznetsova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC "Publishing House OKI"
2020-05-01
|
| Series: | Антибиотики и Химиотерапия |
| Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/201 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Levofloxacin, Lomefloxacin and Moxifloxacin vs. Other Fluoroquinolones in Experimental Plague Due to FI+ and FI<sup>-</sup> Strains of Yersiniapestis in Albino Mice
by: I. V. Ryzhko, et al.
Published: (2020-05-01) -
Fluoroquinolone-Induced Aortic Injury
by: N. V. Izmozherova, et al.
Published: (2021-07-01) -
Children’s preferences among six novel moxifloxacin and linezolid-dispersible tablet formulations
by: G. Hoddinott, et al.
Published: (2025-04-01) -
Prevention of Nosocomial Respiratory Infections
by: N. A. Karpun, et al.
Published: (2007-06-01) -
NOSOCOMIAL INFECTION AND MICROBIAL BIOFILMS IN SURGERY
by: N. I. Gabrielyan, et al.
Published: (2012-09-01)